Page last updated: 2024-11-13
ciguatoxin 2
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
ciguatoxin 2: ciguatoxin -2 is a diastereomer of ciguatoxin-3; differs only in stereochemistry at carbon 52; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 76957583 |
MeSH ID | M0219068 |
Synonyms (15)
Synonym |
---|
ciguatoxin 2 |
ciguatoxin-2 |
ciguatoxin, 54-deoxy- |
ctx 2 |
ciguatoxin ctx 2 |
142185-85-1 |
unii-9fem1mon3p |
9fem1mon3p , |
ctx-2 [mi] |
52-epi-54-deoxyciguatoxin |
ctx-2 |
pacific ciguatoxin 2 |
ciguatoxin 2a2 |
DTXSID401018111 |
Q27272490 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.59
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.59) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |